Skip to main content

Table 3 Findings of studies on HBV prevalence among non-injecting people who use drugs in Irana

From: Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis

No

Author, year

Recruitment setting

Age characteristics

History of incarceration (%)

Sample size (Male, Female)

HBsAg positive cases (%)

Total

Male

Female

1

Moradi, 2019 [49]

Incarcerated

–

NA

3917 (UK)

120 (3.0)

–

–

2

Moradi, 2018 [50]

Incarcerated

–

NA

3400 (UK)

95 (2.8)

–

–

3

Ziaee, 2016 [51]

Community

–

–

139 (UK)

5 (3.6)

–

–

4

Mohammadkhani-Ghiasvand, 2016 [56]

DTC

–

–

186 (UK)

3 (1.3)

–

–

5

Teimori, 2011 [59]

DTC

Mean: 35.2

Range: 20–54

1.3

66 (0, 66)

0 (0)

–

0 (0)

6

Nokhodian, 2012 [63]

Incarcerated

–

–

44 (0, 44)

0 (0)

–

0 (0)

7

Khajedaluee, 2016 [65]

Incarcerated

–

–

495 (UK)

16 (3.2)

–

–

8

Mardani, 2009 [70]

Incarcerated

–

–

164 (UK)

6 (3.7)

–

–

9

Talaei, 2007 [71]

Hospital

–

–

126 (UK)

2 (1.6)

–

–

10

Azarkar, 2007 [73]

Incarcerated

–

–

140 (UK)

6 (4.3)

–

–

11

Khodadadizadeh, 2006 [75]

DTC

–

–

149 (141, 8)

2 (3.7)

1 (0.7)

1 (12.5)

  1. NA not applicable, UK unknown, DTC drug treatment center  
  2. aNo study reported data on the history of high-risk sexual relationships, tattooing, cupping and co-infection with HCV or HIV